TFF Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of TFF Pharmaceuticals, Inc. on 31/03/2021 amounted to 24 315 $. The dynamics of net revenue of TFF Pharmaceuticals, Inc. rose. The change amounted to 24 315 $. The dynamics of net revenue is shown in comparison with the previous report. Net income TFF Pharmaceuticals, Inc. - -7 654 575 $. Information about net income is used from open sources. The financial graph of TFF Pharmaceuticals, Inc. displays the online status: net income, net revenue, total assets. The financial report chart shows the values from 30/09/2018 to 31/03/2021. The value of TFF Pharmaceuticals, Inc. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
24 315 $
-
-7 654 575 $
-
31/12/2020
0 $
-
-5 895 422 $
-
30/09/2020
0 $
-
-5 058 035 $
-
30/06/2020
0 $
-
-3 816 579 $
-
30/09/2019
0 $
-
-2 838 303 $
-
30/06/2019
0 $
-
-2 186 920 $
-
31/03/2019
0 $
-
-2 182 815 $
-
30/09/2018
0 $
-
-585 215 $
-
Show:
to
TFF Pharmaceuticals, Inc. financial report charts
Dates of TFF Pharmaceuticals, Inc. finance reports: 30/09/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of TFF Pharmaceuticals, Inc. is 31/03/2021. Gross profit TFF Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit TFF Pharmaceuticals, Inc. is -5 253 937 $
TFF Pharmaceuticals, Inc. quarterly report dates
Cost of revenue TFF Pharmaceuticals, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue TFF Pharmaceuticals, Inc. is 5 278 252 $ Total revenue TFF Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue TFF Pharmaceuticals, Inc. is 24 315 $ Operating income TFF Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income TFF Pharmaceuticals, Inc. is -7 901 352 $
Net income TFF Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income TFF Pharmaceuticals, Inc. is -7 654 575 $ Current assets TFF Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets TFF Pharmaceuticals, Inc. is 59 776 306 $ Total assets TFF Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets TFF Pharmaceuticals, Inc. is 61 353 747 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-5 253 937 $
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
5 278 252 $
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
24 315 $
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-7 901 352 $
-5 919 029 $
-5 078 581 $
-3 842 574 $
-2 864 168 $
-2 209 109 $
-2 202 460 $
-606 086 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-7 654 575 $
-5 895 422 $
-5 058 035 $
-3 816 579 $
-2 838 303 $
-2 186 920 $
-2 182 815 $
-585 215 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
3 054 583 $
2 823 669 $
2 567 771 $
2 563 528 $
1 319 656 $
1 670 862 $
140 167 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
7 925 667 $
5 919 029 $
5 078 581 $
3 842 574 $
2 864 168 $
2 209 109 $
2 202 460 $
606 086 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
59 776 306 $
37 559 034 $
42 212 907 $
22 534 495 $
10 570 866 $
13 659 204 $
8 176 646 $
10 273 736 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
61 353 747 $
38 661 842 $
43 158 272 $
22 534 495 $
11 032 759 $
13 804 130 $
8 321 572 $
10 401 504 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
58 055 122 $
35 300 805 $
41 617 891 $
21 924 119 $
10 550 569 $
13 632 114 $
8 146 006 $
10 261 671 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
2 188 331 $
1 623 581 $
1 359 931 $
1 156 995 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
2 188 331 $
1 623 581 $
1 359 931 $
1 156 995 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
19.83 %
11.76 %
16.34 %
11.12 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
59 536 713 $
37 339 802 $
41 584 888 $
21 844 692 $
-10 839 769 $
-7 513 815 $
-5 524 330 $
-3 241 462 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-3 071 378 $
-1 722 285 $
-2 115 665 $
-781 218 $
Last revenue report of TFF Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in TFF Pharmaceuticals, Inc. was 24 315 US dollar and changed by 0% since last year. Net income in TFF Pharmaceuticals, Inc. was -7 654 575 $ in last quartal, net income changes to 0%.
Current cash TFF Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash TFF Pharmaceuticals, Inc. is 58 055 122 $
TFF Pharmaceuticals, Inc. stocks data
TFFP stock price
TFF Pharmaceuticals, Inc. stock price today, TFFP stock quote.
